procainamide has been researched along with Kidney Neoplasms in 1 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
Kidney Neoplasms: Tumors or cancers of the KIDNEY.
Excerpt | Relevance | Reference |
---|---|---|
" On the other hand, the combined treatment with these two drugs induced effective anti-tumour efficacy in the relative mean tumour weight ratio (TRW/CRW), mean tumour weight and the survival rate compared with the control and each monotherapy, especially in the administration of Procainamide dosed at 30 mg/kg." | 1.30 | [Study on the combined therapy of DNA-methyltransferase inhibitor and interferon-alpha/beta for mouse spontaneously arose renal cell carcinoma, and immunological mechanism induced by the therapy]. ( Abe, K; Asano, K; Goto, H; Hatano, T; Imagawa, K; Ohishi, Y; Onishi, T; Suzuki, H; Tomita, M, 1998) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Onishi, T | 1 |
Ohishi, Y | 1 |
Goto, H | 1 |
Suzuki, H | 1 |
Asano, K | 1 |
Hatano, T | 1 |
Abe, K | 1 |
Tomita, M | 1 |
Imagawa, K | 1 |
1 other study available for procainamide and Kidney Neoplasms
Article | Year |
---|---|
[Study on the combined therapy of DNA-methyltransferase inhibitor and interferon-alpha/beta for mouse spontaneously arose renal cell carcinoma, and immunological mechanism induced by the therapy].
Topics: Animals; Carcinoma, Renal Cell; DNA-Cytosine Methylases; Enzyme Inhibitors; Immunity, Cellular; Inte | 1998 |